TRVI – trevi therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024 [Yahoo! Finance]
Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024
Trevi Therapeutics, Inc. (NASDAQ: TRVI) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $8.00 price target on the stock.
Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference [Yahoo! Finance]
Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference
Form ARS Trevi Therapeutics, Inc. For: Dec 31
Form DEFA14A Trevi Therapeutics, Inc.
Form DEF 14A Trevi Therapeutics, Inc. For: Jun 13
Form SC 13G/A Trevi Therapeutics, Inc. Filed by: Rosalind Advisors, Inc.
Form S-8 Trevi Therapeutics, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.